Elevance Health, Inc. Website

Elevance Health, Inc.

NYSE-ELV

Basic

  • Market Cap

    $115.97B

  • EV

    $137.27B

  • Shares Out

    231.89M

  • Revenue

    $171.72B

  • Employees

    104,900

Margins

  • Gross

    28.34%

  • EBITDA

    6.63%

  • Operating

    6.14%

  • Pre-Tax

    5%

  • Net

    3.9%

  • FCF

    0.48%

Returns (5Yr Avg)

  • ROA

    5.95%

  • ROTA

    22.43%

  • ROE

    16%

  • ROCE

    14.16%

  • ROIC

    11.94%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $602.5

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $6,497M

  • Net Debt

    $21.19B

  • Debt/Equity

    0.65

  • EBIT/Interest

    9.92

Growth (CAGR)

  • Rev 3Yr

    9.94%

  • Rev 5Yr

    12.16%

  • Rev 10Yr

    9.07%

  • Dil EPS 3Yr

    18.99%

  • Dil EPS 5Yr

    12.96%

  • Dil EPS 10Yr

    14.19%

  • Rev Fwd 2Yr

    3.55%

  • EBITDA Fwd 2Yr

    9.54%

  • EPS Fwd 2Yr

    12.12%

  • EPS LT Growth Est

    9.4%

Dividends

  • Yield

  • Payout

    21.72%

  • DPS

    $6.22

  • DPS Growth 3Yr

    14.35%

  • DPS Growth 5Yr

    14.94%

  • DPS Growth 10Yr

    14.37%

  • DPS Growth Fwd 2Yr

    7.31%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Premiums and Annuity Revenues

94,173

104,109

117,373

133,229

142,854

141,509

Total Interest And Dividend Income

1,005

877

1,378

1,485

1,825

1,995

Gain (Loss) on Sale of Investments, Total

Other Revenues, Total

9,034

16,882

19,892

21,885

26,661

28,215

Total Revenues

104,212

121,868

138,643

156,599

171,340

171,719

Total Revenues % Chg.

13.2%

16.9%

13.8%

13%

9.4%

3.6%

Policy Benefits

81,786

88,045

102,571

116,642

124,330

123,058

Amortization of Goodwill and Intangible Assets

338

361

441

767

885

707

Selling General & Admin Expenses, Total

15,356

25,202

26,604

30,696

36,236

37,407

Total Operating Expenses

97,480

113,608

129,616

148,105

161,451

161,172

Operating Income

6,732

8,260

9,027

8,494

9,889

10,547

Interest Expense, Total

-745

-785

-802

-855

-1,030

-1,063

EBT, Excl. Unusual Items

5,987

7,475

8,225

7,639

8,859

9,484

Restructuring Charges

-653

-202

-39

-752

-752

Gain (Loss) on Sale of Assets

240

Asset Writedown

-7

-392

-392

Legal Settlements

-548

Other Unusual Items

-2

-36

-21

EBT, Incl. Unusual Items

5,985

6,238

7,995

7,600

7,715

8,580

Income Tax Expense

1,178

1,666

1,846

1,712

1,724

1,899

Earnings From Continuing Operations

4,807

4,572

6,149

5,888

5,991

6,681

Earnings Of Discontinued Operations

Minority Interest

9

6

-4

10

Net Income

4,807

4,572

6,158

5,894

5,987

6,691

Net Income to Common Incl Extra Items

4,807

4,572

6,158

5,894

5,987

6,691

Net Income to Common Excl. Extra Items

4,807

4,572

6,158

5,894

5,987

6,691

Total Shares Outstanding

252.9

245.4

241.8

238

233.1

231.9

Weighted Avg. Shares Outstanding

255.5

250.8

243.8

240

235.9

233.6

Weighted Avg. Shares Outstanding Dil

260.3

254.3

246.8

242.8

237.4

235

EPS

18.8

18.2

25.3

24.6

25.4

28.6

EPS Diluted

18.5

18

25

24.3

25.2

28.5

EBITDA

7,415

9,002

9,844

9,570

10,949

11,378

Effective Tax Rate

19.7%

26.7%

23.1%

22.5%

22.3%

22.1%